Targeting MCL-1 protein to treat cancer: opportunities and challenges.

Tantawy, Shady I; Timofeeva, Natalia; Sarkar, Aloke; Gandhi, Varsha

Tantawy, Shady I; Timofeeva, Natalia; Sarkar, Aloke; Gandhi, Varsha.

Afiliación

Tantawy SI; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Timofeeva N; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Sarkar A; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Gandhi V; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Front Oncol ; 13: 1226289, 2023.

Article en En | MEDLINE | ID: mdl-37601693

Palabras clave

BCL-2 family; BCL-2 family proteins; MCL-1 inhibitors; MCL-1 protein; apoptosis; cancer therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google